# US 2011/0258715 A1 · ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0258715 A1
- Document ID: US20110258715A1
- Status: Published application
- Kind: A1
- Application number: 13/059,941
- Filed: 2009-08-21
- Published: 2011-10-20
- Earliest claimed: 2008-08-22
- Assignees: The University of Tokyo
- Inventors: Hiromitsu Nakauchi; Toshihiro Kobayashi; Tomoyuki Yamaguchi; Sanae Hamanaka
- Web page: https://patentgrep.com/patent/US20110258715A1

## CPC

- A01K 67/0271: Chimeric vertebrates, e.g. comprising exogenous cells
- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- A01K 67/0276: Knock-out vertebrates
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/3839: {characterised by the site of application in the body (materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60)}
- A61L 27/3895: {using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions}
- A01K 2207/12: Animals modified by administration of exogenous cells
- A01K 2227/105: Murine
- A01K 2267/025: Animal producing cells or organs for transplantation
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

It is revealed that an organ such as pancreas can be regenerated by utilizing a fact that the deficiency of an organ is complemented by injecting an induced pluripotent stem cell (iPS cell) into a developed blastocyst in a blastocyst complementation method. Thus, the present invention has solved the above-described object. This provides a method for producing a target organ, using an iPS cell, in a living body of a non-human mammal having an abnormality associated with a lack of development of the target organ in a development stage, the target organ produced being derived from a different individual mammal that is an individual different from the non-human mammal.

## Claims

### Claim 1

A method for producing a target organ in a living body of a non-human mammal having an abnormality associated with a lack of development of the target organ in a development stage, the target organ produced being derived from a different individual mammal that is an individual different from the non-human mammal, the method comprising the steps:
a) preparing an induced pluripotent stem cell (iPS cell) derived from the different individual mammal;
b) transplanting the cell into a blastocyst stage fertilized egg of the non-human mammal;
c) developing the fertilized egg in a womb of a non-human surrogate parent mammal to obtain a litter; and
d) obtaining the target organ from the litter individual.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the iPS cell is derived from any one of a human, a rat, and a mouse.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the iPS cell is derived from any one of a rat and a mouse.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the organ to be produced is selected from a pancreas, a kidney, a thymus, and a hair.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the non-human mammal is a mouse.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the mouse is any one of a Sall1 knockout mouse, a Pdx1-Hes1 transgenic mouse, a Pdx1 knockout mouse, and a nude mouse.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the target organ is completely derived from the different individual mammal.

### Claim 8 (depends on 1)

The method according to claim 1, further comprising a step of bringing a reprogramming factor into contact with a somatic cell to obtain the iPS cell.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the iPS cell and the non-human mammal are in a xenogeneic relationship.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the iPS cell is derived from a rat, and the non-human mammal is a mouse.

### Claim 11

A non-human mammal having an abnormality associated with a lack of development of a target organ in a development stage, the mammal being produced by a method including the steps of:
a) preparing an iPS cell derived from a different individual mammal that is an individual different from the non-human mammal;
b) transplanting the iPS cell into a blastocyst stage fertilized egg of the non-human mammal; and
c) developing the fertilized egg in a womb of a non-human surrogate parent mammal to obtain a litter.

### Claim 12

Use of a non-human mammal having an abnormality associated with a lack of development of a target organ in a development stage, for production of the target organ using an iPS cell.

### Claim 13

A set for producing a target organ, the set comprising:
A) a non-human mammal having an abnormality associated with a lack of development of the target organ in a development stage; and
B) any one of
an iPS cell derived from a different individual mammal that is an individual different from the non-human mammal, and
a reprogramming factor and, if necessary, a somatic cell.

### Claim 14

A method for producing any one of a target organ and a target body part, the method comprising the steps of:
A) providing an animal which includes a deficiency responsible gene coding for a factor which causes a deficiency of any one of an organ and a body part and gives any one of no possibility of survival and difficulty in survival if the factor functions, and in which the any one of an organ and a body part is complemented by blastocyst complementation, the deficiency responsible gene coding for a factor which causes a deficiency of the any one of a target organ and a target body part;
B) growing an ovum obtained from the animal into a blastocyst;
C) introducing a target iPS cell into the blastocyst so as to produce a chimeric blastocyst, the target iPS cell having a desired genome capable of complementing a deficiency caused by the deficiency responsible gene; and
D) producing an individual from the chimeric blastocyst, and then obtaining the any one of a target organ and a target body part from the individual.

### Claim 15 (depends on 14)

The method according to claim 14, further comprising a step of bringing a reprogramming factor into contact with a somatic cell to obtain the iPS cell.

### Claim 16 (depends on 14)

The method according to claim 14, wherein the step D) includes developing the chimeric blastocyst in a womb of a non-human surrogate parent mammal to obtain a litter, and obtaining the target organ from the litter individual.

### Claim 17 (depends on 14)

The method according to claim 14, wherein the target iPS cell is derived from any one of a rat and a mouse.

### Claim 18 (depends on 14)

The method according to claim 14, wherein the any one of a target organ and a target body part is selected from a pancreas, a kidney, a thymus, and a hair.

### Claim 19 (depends on 14)

The method according to claim 14, wherein the animal is a mouse.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the mouse is any one of a Sall1 knockout mouse, a Pdx1 knockout mouse, a Pdx1-Hes1 transgenic mouse, and a nude mouse.

### Claim 21 (depends on 14)

The method according to claim 14, wherein the anyone of a target organ and a target body part is completely derived from the target pluripotent cell.

### Claim 22 (depends on 14)

The method according to claim 14, wherein the iPS cell and the non-human mammal are in a xenogeneic relationship.

### Claim 23 (depends on 14)

The method according to claim 14, wherein the iPS cell is derived from a rat, and the non-human mammal is a mouse.

### Claim 24

A set for producing any one of a target organ and a target body part, the set comprising:
A) a non-human animal which includes a gene coding for a factor which causes a deficiency of any one of an organ and a body part and gives any one of no possibility of survival and difficulty in survival if the factor functions, and in which the any one of an organ and a body part is complemented by complement; and
B) any one of
an iPS cell derived from a different individual mammal that is an individual different from the non-human mammal, and
a combination of a reprogramming factor and, if necessary, a somatic cell.

### Claim 25 (depends on 24)

The set according to claim 24, wherein the non-human animal and the iPS cell are in a xenogeneic relationship.
